Shire
Clinical trials sponsored by Shire, explained in plain language.
-
New hope for kids whose ADHD Doesn't respond to common meds
Disease control CompletedThis study tested a long-acting, non-stimulant medication called guanfacine for children and teenagers (ages 6-17) with ADHD who could not take or did not benefit from standard stimulant medications. It aimed to see if the drug safely improves attention, behavior, and thinking sk…
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
3-Year study tests Real-World impact of HAE prevention drug
Disease control CompletedThis study followed 140 people with hereditary angioedema (HAE) for up to three years to see how well the drug lanadelumab worked in everyday life. The main goal was to compare the number of HAE attacks people had while on the drug to the number they had before starting it. Parti…
Sponsor: Shire • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Researchers ask: do patients and doctors understand this Drug's risks?
Knowledge-focused CompletedThis study was a survey to check how much patients and their doctors know about the risks and safe use of the drug NATPARA for hypoparathyroidism. About 200 people, including patients and prescribing doctors, answered true/false questions online, by phone, or on paper. No medicat…
Sponsor: Shire • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
First look: how bodies process new drug differs by ethnicity
Knowledge-focused CompletedThis early-stage study aimed to understand how a drug called maribavir is processed by the body in healthy Japanese adults compared to healthy Caucasian adults. It involved 24 healthy volunteers and tested single oral doses. The main goal was to see if the drug's levels in the bl…
Phase: PHASE1 • Sponsor: Shire • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC